Patient support programs (PSPs) are pivotal in enhancing drug access, utilization, and adherence. Despite substantial investments, the enrollment for these programs often falls short of expectations. Overcoming this challenge necessitates a data-driven strategy, leveraging the power of artificial intelligence and machine learning (AI/ML).